Xavier University of Louisiana College of Pharmacy Curriculum Map

1
Xavier University of LouisianaCollege of
Pharmacy Curriculum Map NAPLEX Competencies

• Primary Analysis
• Completed by ADPA

2
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management
1.1.1 Identify and assess patient information including medication, laboratory and disease state histories. 1.1.1 Identify and assess patient information including medication, laboratory and disease state histories.
CBCO Should this competency be introduced in the first year?
Teaching Methods Active learning 4/6 courses occurs in the 3rd and 4th year Lecture 3/6 courses Other need to define-3 courses
Assessment Methods Performance based 4/6 courses occurs in the 3rd and 4th year Test/quiz 4/6 courses Other-need to define-1 course
3
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management
1.1.2 Identify and/or use instruments and techniques related to patient assessment and diagnosis. 1.1.2 Identify and/or use instruments and techniques related to patient assessment and diagnosis.
CBCO Should this competency be introduced in the first year?
Teaching Methods Active Learning 5/7 courses occurs in the 2nd 4th year Lecture 4/7 courses Other-need to define-2 courses
Assessment Methods Performance based 4/7 courses occurs in the 3rd and 4th year Test/quiz 4/7 courses
4
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management
1.1.3 Identify and define the terminology, signs and symptoms associated with diseases and medical conditions. 1.1.3 Identify and define the terminology, signs and symptoms associated with diseases and medical conditions.
CBCO Reinforced in the fourth year
Teaching Methods Active Learning 4/9 courses occurs in the 2nd 4th year Lecture 7/9 courses Other-need to define 3 courses
Assessment Methhods Performance based 3/9 courses occurs in the 3rd and 4th year Test/quiz 7/9 courses Other-need to define 1 course
5
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management
1.1.4 Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition. 1.1.4 Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition.
CBCO Introduced and Reinforced in the 4th year
Teaching Methods Active learning 4/8 courses occurs in the 3rd and 4th year Lecture 5/8 courses Other-need to define-2 courses
Assessment Methods Performance based-4/8 occurs in the 3rd and 4th year Test/quiz- 6/8 courses Other-need to define-2 courses
6
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.1 Identify specific uses and indications for drug products. 1.2.1 Identify specific uses and indications for drug products.
CBCO Reinforced in the 4th year
Teaching Methods Active learning 4/11 courses occurs in the 3rd and 4th year Lecture 7/11 courses Other-need to define-2 courses
Assessment Methods Performance based-4/11 courses occurs in the 3rd and 4th year Test/quiz-9/11 courses
7
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.2 Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents. 1.2.2 Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents.
CBCO Reinforced in the fourth year
Teaching Methods Active learning-4/10 courses occurs in the 3rd and 4th year Lecture-7/10 courses Other-need to define-3 courses
Assessment Methods Performance based-5/10 courses occurs in the 2nd-4th year Test/quiz-9/10 courses
8
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.3 Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures. 1.2.3 Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures.
CBCO Introduced in the 3rd year reinforced in the 4th year
Teaching methods Active learning-5/7 courses occurs in the 2nd-4th year Lecture-3/7 courses Other-need to define-2 courses
Assessment Methods Performance based-4/7 courses occurs in the 3rd and 4th year Test/quiz-4/7 courses
9
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.4 Identify contraindications, warnings, and precautions associated with a drug products active and inactive ingredients. 1.2.4 Identify contraindications, warnings, and precautions associated with a drug products active and inactive ingredients.
CBCO Reinforced in the 4th year
Teaching Methods Active learning-5/9 courses occurs in the 2nd - 4th year Lecture-6/9 courses Other-need to define-2 courses
Assessment Methods Performance based-5/9 courses occurs in the 3rd and 4th year Test/quiz-8/9
10
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.5 Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. 1.2.5 Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability.
CBCO Reinforced in the 4th year
Teaching Methods Active learning-4/12 occurs in the 3rd and 4th year Lecture-8/12 courses Other-need to define-2 courses
Assessment Methods Performance based-7/12 courses occurs in each year Test/quiz-8/12 courses
11
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.6 Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens. 1.2.6 Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens.
CBCO Reinforced in the 4th year
Teaching Methods Active learning-4/9 courses occurs in the 3rd and 4th year Lecture-7/9 courses Other-need to define2 courses
Assessment Methods Performance based-6/9 courses occurs in each year Test/quiz-7/9 courses
12
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.0 Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patients specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems.
1.2.7 Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance. 1.2.7 Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance.
CBCO Reinforced in the 4th year
Teaching Methods Active learning-4/9 courses occurs in the 3rd and 4th year Lecture-5/9 courses Other-need to define-1 course
Assessment Methods Performance based-5/9 courses occurs in the 2nd-4th year Test/quiz-6/9 courses
13
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education.
1.3.1 Identify pharmacotherapeutic outcomes and endpoints. 1.3.1 Identify pharmacotherapeutic outcomes and endpoints.
CBCO Introduced in the 3rd year Reinforced in the 4th year
Teaching Methods Active learning-4/7 courses occurs in the 3rd and 4th year Lecture-4/7 courses Other-need to define-1 course
Assessment Methods Performance based-4/7 courses occurs in the 3rd and 4th year Test/quiz-5/7 courses
14
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education.
1.3.2 Evaluate patient signs and symptoms, and the results of monitoring tests and procedures to determine the safety and effectiveness of pharmacotherapy. 1.3.2 Evaluate patient signs and symptoms, and the results of monitoring tests and procedures to determine the safety and effectiveness of pharmacotherapy.
CBCO Introduced in the 3rd year Reinforced in the 4th year
Teaching Methods Active learning-4/5 courses occurs in the 2nd-4th year Lecture-3/5 courses Other-need to define-2 courses
Assessment Methods Performance based-3/5 courses occurs in the 3rd and 4th year Test/quiz-4/5 courses
15
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education.
1.3.3 Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness. 1.3.3 Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness.
CBCO Introduced in the 3rd year reinforced in the 4th year
Teaching Methods Active learning-4/8 courses occurs in the 3rd and 4th year Lecture-5/8 courses Other-need to define-2 courses
Assessment Methods Performance based-4/8 courses occurs in the 3rd and 4th year Test/quiz-4/8 courses
16
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education.
1.3.4 Prevent, recognize, and remedy medication non-adherence, misuse or abuse. 1.3.4 Prevent, recognize, and remedy medication non-adherence, misuse or abuse.
CBCO Introduced in the 3rd year reinforced in the 4th year
Teaching Methods Active learning-4/6 courses occurs in the 3rd and 4th year Lecture-3/6 courses Other-need to define-2 courses
Assessment Methods Performance based-4/6 courses occurs in the 3rd and 4th year Test/quiz-2/6 courses
17
Area 1 - Assure Safe and Effective
Pharmacotherapy and Optimize Therapeutic Outcomes
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education.
1.3.5 Recommend pharmacotherapeutic alternatives. 1.3.5 Recommend pharmacotherapeutic alternatives.
CBCO Introduced in the 3rd year reinforced in the 4th year
Teaching Methods Active learning-4/7 courses occurs in the 2nd-4th year Lecture-5/7 courses Other-need to define- 2 courses
Assessment Methods Performance based-3/7 courses occurs in the 3rd and the 4th year Test/quiz-6/7 courses
18
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 Perform calculations required to compound, dispense, and administer medication. 2.1.0 Perform calculations required to compound, dispense, and administer medication.
2.1.1 Calculate the quantity of medication to be compounded or dispensed reduced and enlarge formulation quantities and calculate the quantity of ingredients needed to compound the proper amount of the preparation. 2.1.1 Calculate the quantity of medication to be compounded or dispensed reduced and enlarge formulation quantities and calculate the quantity of ingredients needed to compound the proper amount of the preparation.
CBCO Introduced in the 3rd year reinforced in the 1st year this competency is covered in only 3 courses
Teaching Methods Active learning-1/3 courses occurs in the 3rd year Lecture-2/3 courses
Assessment Methods Performance based-2/3 courses occurs in the 2nd and 3rd year Test/quiz-1/3 courses
19
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 Perform calculations required to compound, dispense, and administer medication. 2.1.0 Perform calculations required to compound, dispense, and administer medication.
2.1.2 Calculate nutritional needs and the caloric content of nutrient sources. 2.1.2 Calculate nutritional needs and the caloric content of nutrient sources.
Comments This competency is only covered in one course
20
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 Perform calculations required to compound, dispense, and administer medication. 2.1.0 Perform calculations required to compound, dispense, and administer medication.
2.1.3 Calculate the rate of drug administration. 2.1.3 Calculate the rate of drug administration.
CBCO Appears to be okay.
Teaching Methods Active learning-1/4 courses occurs in the 3rd year Lecture-3/4 courses
Assessment Methhods Performance based-1/4 courses occurs in the 3rd year Test/quiz-3/4 courses
21
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 Perform calculations required to compound, dispense, and administer medication. 2.1.0 Perform calculations required to compound, dispense, and administer medication.
2.1.4 Calculate or convert drug concentrations, ratio strengths, and/or extent of ionization. 2.1.4 Calculate or convert drug concentrations, ratio strengths, and/or extent of ionization.
CBCO Appears to be okay.
Teaching Methods Active learning-1/4 courses occurs in the 3rd year Lecture-4/4 courses
Assessment Methods Performance based-2/4 courses occurs in the 2nd and 3rd year Test/quiz-3/4 courses
22
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.1 Identify drug products by their generic, brand, and/or common names. 2.2.1 Identify drug products by their generic, brand, and/or common names.
CBCO Reinforced in the fourth year
Teaching Methods Active learning-2/9 courses occurs in the 3rd and 4th year Lecture-5/9 courses Other-need to define-2 courses
Assessment Methods Performance based-2/9 courses occurs in the 3rd and 4th year Test/quiz 8/9 courses
23
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.2 Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis. 2.2.2 Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis.
CBCO Introduced in the 4th year
Teaching Methods Active learning-2/7 courses occurs in the 3rd and 4th year Lecture-4/7 courses Other-need to define-2 courses
Assessment Methods Performance based-2/7 courses occurs in the 3rd and 4th year Test/quiz-3/7 courses Other-need to define-1 course
24
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.3 Identify commercially available drug products by their characteristic physical attributes. 2.2.3 Identify commercially available drug products by their characteristic physical attributes.
CBCO This competency is only covered in 1 course.


25
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.4 Interpret and apply pharmacokinetic parameters and quality assurance data to determine equivalence among manufactured drug products, and identify products for which documented evidence of inequivalence exists. 2.2.4 Interpret and apply pharmacokinetic parameters and quality assurance data to determine equivalence among manufactured drug products, and identify products for which documented evidence of inequivalence exists.
CBCO Appears to be okay
Teaching Methods Active learning-1/4 courses occurs in the 3rd year Lecture-2/4 courses Other-need to define-1 course
Assessment Methods Performance based 0/4 courses Test/quiz-2/4 courses Other-need to define-1 course
26
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.5 Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications. 2.2.5 Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications.
CBCO Introduced in the 3rd and 4th year
Teaching Methods Active learning-2/7 courses occurs in the 3rd and 4th year Lecture-4/7 courses Other-need to define-2 courses
Assessment Methods Performance based-1/7 courses occurs in the 4th year Test/quiz-4/7 courses Other-need to define-1 course
27
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 Select and dispense medications in a manner that promotes safe and effective use. 2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.6 Identify and describe the use of equipment and apparatus required to administer medications. 2.2.6 Identify and describe the use of equipment and apparatus required to administer medications.
CBCO Introduced in the 3rd year this competency is not reinforced
Teaching Methods Active learning 3/6 courses occurs in the 3rd and 4th year Lecture-3/6 courses Other-need to define-1 course
Assessment Methods Performance based-1/6 courses occurs in the 3rd year Test/quiz-2/6 courses Other-need to define-3 courses
28
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 Prepare and compound extemporaneous preparations and sterile products. 2.3.0 Prepare and compound extemporaneous preparations and sterile products.
2.3.1 Identify and describe techniques and procedures related to drug preparation, compounding and quality assurance. 2.3.1 Identify and describe techniques and procedures related to drug preparation, compounding and quality assurance.
CBCO Introduced in the 3rd year
Teaching Methods Active learning-1/4 courses occurs in the 3rd year Lecture-3/4 courses
Assessment Methods Performance based-1/4 courses occurs in the 2nd year Test/quiz-3/4 courses
29
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 Prepare and compound extemporaneous preparations and sterile products. 2.3.0 Prepare and compound extemporaneous preparations and sterile products.
2.3.2 Identify and use equipment necessary to prepare and extemporaneously compound medications. 2.3.2 Identify and use equipment necessary to prepare and extemporaneously compound medications.
CBCO Introduced in the 3rd year this competency is not reinforced
Teaching Methods Active learning-1/3 courses occurs in the 3rd year Lecture-2/3 courses
Assessment Methods Performance based-1/3 courses occurs in the 2nd year Test/quiz-2/3 courses
30
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 Prepare and compound extemporaneous preparations and sterile products. 2.3.0 Prepare and compound extemporaneous preparations and sterile products.
2.3.3 Identify the important physiochemical properties of a preparations active and inactive ingredients describe the mechanism of, and the characteristic evidence of incompatibility or degradation and identify methods for achieving stabilization of the preparation 2.3.3 Identify the important physiochemical properties of a preparations active and inactive ingredients describe the mechanism of, and the characteristic evidence of incompatibility or degradation and identify methods for achieving stabilization of the preparation
CBCO Introduced in the 3rd year this competency is not emphasized
Teaching methods Active learning-1/7 courses occurs in the 3rd year Lecture-6/7 courses
Assessment Methods Performance based-2/7 courses occurs in the 2nd year Test/quiz-5/7 courses
31
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 Access, evaluate, and apply information to promote optimal health care. 3.1.0 Access, evaluate, and apply information to promote optimal health care.
3.1.1 Identify the typical content and organization of specific sources of drug and health information for both health care providers and consumers. 3.1.1 Identify the typical content and organization of specific sources of drug and health information for both health care providers and consumers.
CBCO Introduced and reinforced in the 4th year introduced in the 3rd year
Teaching Methods Active learning-3/3 courses occurs in the 1st, 3rd, and 4th year Lecture-1/3 courses Other-need to define-2 courses
Assessment Methods Performance based-3/3 courses occurs in the 1st, 3rd, and 4th year Test/quiz-0/3 courses Other-need to define-1 course
32
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 Access, evaluate, and apply information to promote optimal health care. 3.1.0 Access, evaluate, and apply information to promote optimal health care. 3.1.0 Access, evaluate, and apply information to promote optimal health care. 3.1.0 Access, evaluate, and apply information to promote optimal health care.
3.1.2 Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters. 3.1.2 Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters. 3.1.2 Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters. 3.1.2 Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters.
Course CBCO Teaching method(s) Assessment method(s)
PSL I I O, SGD, L IGP, HW, OP, P, RP
Biopharmaceutics R L T
IPPE III I SGD RP, OP, IGP
Clinical Rotation R, E O, CS, SGD O, OP


33
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices.
3.2.1 Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care. 3.2.1 Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care. 3.2.1 Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care. 3.2.1 Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care.
Course CBCO Teaching method(s) Assessment method(s)
Pharmacy Law R L T
IPPE III I SGD IGP
Clinical Rotation R, E O, SGD D, HW, OP



34
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices.
3.2.2 Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition. 3.2.2 Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition. 3.2.2 Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition. 3.2.2 Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition.
Course CBCO Teaching method(s) Assessment method(s)
Biochemistry I L T
Pharmacy Practice R CS OP, IGP
Pharmacy Law R L T
IPPE III I SGD ?
Clinical Rotation R, E SGD, O OP, D

35
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices.
3.2.3 Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements. 3.2.3 Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements. 3.2.3 Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements. 3.2.3 Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements.
Course CBCO Teaching method(s) Assessment method(s)
Pharmacy Practice E CS RP, OP, IGP
Pharmacy Law R L T
IPPE III I SGD ?
Clinical Rotation R, E SGD, CS, O OP, IGP, D


36
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.0 Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices.
3.2.4 Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions. 3.2.4 Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions. 3.2.4 Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions. 3.2.4 Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions.
Course CBCO Teaching method(s) Assessment method(s)
Pharmacy Law R L T
Clinical Rotation R, E SGD, O OP, D